Literature DB >> 13698155

Variations in the natural history of psoriasis.

E M FARBER, J B PETERSON.   

Abstract

Latent psoriasis is a state which exists before the development of clinical psoriasis and wherein probably some as yet undiscovered defect exists. Investigation concerning a group of persons with latent psoriasis might disclose basic aberrations. The natural course of psoriasis may be altered by therapy. Folic acid antagonists and intradermal corticosteroids may at times eclipse psoriatic lesions. Oral adrenal corticosteroids may prove morbidistatic but on discontinuance a rebound flare may occur which is both protracted and recalcitrant. Antimalarial agents when employed as therapy for coexistent arthridites may cause psoriasis to become more severe. The Goeckerman regimen which employs topical tar and ultraviolet light therapy produces in some 75 per cent of patients a prolonged remission. As it is safe and repeatable it is favored for the usual severe case of psoriasis. Psoriasis therapy is better assessed by considering its effect on the natural evolution of the disease.

Entities:  

Keywords:  PSORIASIS

Mesh:

Substances:

Year:  1961        PMID: 13698155      PMCID: PMC1574454     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  10 in total

1.  Studies on the chemical composition of psoriatic scales.

Authors:  V R WHEATLEY; E M FARBER
Journal:  J Invest Dermatol       Date:  1961-03       Impact factor: 8.551

2.  Further observations on aminopterin for psoriasis.

Authors:  R B REES; J H BENNETT
Journal:  J Invest Dermatol       Date:  1959-01       Impact factor: 8.551

3.  Studies on the chemical composition of human epidermal lipids.

Authors:  R P REINERTSON; V R WHEATLEY
Journal:  J Invest Dermatol       Date:  1959-01       Impact factor: 8.551

4.  Treatment of psoriasis with subdermal infiltration of triamcinolone diacetate suspension.

Authors:  A G GERARD
Journal:  Arch Dermatol       Date:  1960-04

5.  Aminopterin for psoriasis.

Authors:  R B REES; J H BENNETT; W L BOSTICK
Journal:  AMA Arch Derm       Date:  1955-08

6.  The prospect of psoriasis.

Authors:  R CHURCH
Journal:  Br J Dermatol       Date:  1958-04       Impact factor: 9.302

7.  Treatment of psoriasis with folic acid antagonists.

Authors:  W F EDMUNDSON; W B GUY
Journal:  AMA Arch Derm       Date:  1958-08

8.  Atabrine in psoriasis.

Authors:  L ZIPRKOWSKI; S HAIM; H BANK
Journal:  Acta Med Orient       Date:  1954 Mar-Apr

9.  The mode of action of folic acid antagonists on cells.

Authors:  W JACOBSON
Journal:  J Physiol       Date:  1954-03-29       Impact factor: 5.182

10.  Psoriasis following infections with hemolytic streptococci.

Authors:  R NORRLIND
Journal:  Acta Derm Venereol       Date:  1950       Impact factor: 4.437

  10 in total
  7 in total

1.  [On the morphogenesis of psoriatic skin reactions. Amorphologico-histochemical study].

Authors:  O BRAUN-FALCO
Journal:  Arch Klin Exp Dermatol       Date:  1963

Review 2.  A current review of psoriasis.

Authors:  E M Farber; R P McClintock
Journal:  Calif Med       Date:  1968-06

3.  Studies on the nature and managment of psoriasis.

Authors:  E M Farber
Journal:  Calif Med       Date:  1971-06

4.  [On the histotopy of enzymes of energy producing metabolism in the epidermis in psoriasis vulgaris].

Authors:  O Braun-Falco; D Petzoldt
Journal:  Arch Klin Exp Dermatol       Date:  1967

5.  [On the diagnosis of latent psoriasis].

Authors:  J Konopík; F Záruba; I Belsan; C Krs; E Zvĕreva; I Spanlangová
Journal:  Arch Klin Exp Dermatol       Date:  1966

6.  Psoriasis in childhood.

Authors:  E M Farber; R A Carlsen
Journal:  Calif Med       Date:  1966-12

7.  The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men.

Authors:  David Hägg; Marie Eriksson; Anders Sundström; Marcus Schmitt-Egenolf
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.